Skip to content
★ Sign in to follow
Total declarations
12
Company
1
▲ Purchases (1 ops.)
€8,249
▼ Sales (1 ops.)
€318k

Latest filing published 16 Jun 2017 for Celldex Therapeutics, Inc..

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Harry Penner Jr.: trading record in brief

All filings by Harry Penner Jr. on record concern Celldex Therapeutics, Inc. In total, 12 filings cover trades dated from 23 December 2009 to 15 June 2017.

Both buying and selling appear: 1 purchase worth €8,249, against 1 sale worth €318k. On balance, insiders were net sellers of €309k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 9 share grants and 1 option exercise.

Most recently, on 16 June 2017, the filings show a share grant in Celldex Therapeutics, Inc. The latest purchase dates back some time: it was published 5,905 days ago, on 9 September 2010. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Harry Penner Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations